List of Contents

Neurovascular Catheters Market Size, Share, and Trends 2024 to 2034

The global neurovascular catheters market size was USD 5.47 billion in 2023, calculated at USD 5.91 billion in 2024 and is expected to reach around USD 12.43 billion by 2034, expanding at a CAGR of 7.7% from 2024 to 2034.

  • Last Updated : August 2024
  • Report Code : 3234
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Neurovascular Catheters Market 

5.1. COVID-19 Landscape: Neurovascular Catheters Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Neurovascular Catheters Market, By Type

8.1. Neurovascular Catheters Market Revenue and Volume, by Type, 2024-2034

8.1.1 Microcatheters

8.1.1.1. Market Revenue and Volume Forecast (2021-2034)

8.1.2. Balloon Catheters

8.1.2.1. Market Revenue and Volume Forecast (2021-2034)

8.1.3. Access Catheters

8.1.3.1. Market Revenue and Volume Forecast (2021-2034)

8.1.4. Embolization Catheters

8.1.4.1. Market Revenue and Volume Forecast (2021-2034)

8.1.5. Others

8.1.5.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 9. Global Neurovascular Catheters Market, By Application

9.1. Neurovascular Catheters Market Revenue and Volume, by Application, 2024-2034

9.1.1. Embolic Stroke

9.1.1.1. Market Revenue and Volume Forecast (2021-2034)

9.1.2. Brain Aneurysms

9.1.2.1. Market Revenue and Volume Forecast (2021-2034)

9.1.3. Arteriovenous Malformations

9.1.3.1. Market Revenue and Volume Forecast (2021-2034)

9.1.4. Others

9.1.4.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 10. Global Neurovascular Catheters Market, By End Use 

10.1. Neurovascular Catheters Market Revenue and Volume, by End Use, 2024-2034

10.1.1. Hospital

10.1.1.1. Market Revenue and Volume Forecast (2021-2034)

10.1.2. Clinics

10.1.2.1. Market Revenue and Volume Forecast (2021-2034)

10.1.3. Ambulatory Surgical Centers

10.1.3.1. Market Revenue and Volume Forecast (2021-2034)

10.1.4. Diagnostic Centers

10.1.4.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 11. Global Neurovascular Catheters Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.1.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.1.3. Market Revenue and Volume Forecast, by End Use (2021-2034)

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.1.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.1.4.3. Market Revenue and Volume Forecast, by End Use (2021-2034)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.1.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.1.5.3. Market Revenue and Volume Forecast, by End Use (2021-2034)

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.2.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.2.3. Market Revenue and Volume Forecast, by End Use (2021-2034)

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.2.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.2.4.3. Market Revenue and Volume Forecast, by End Use (2021-2034)

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.2.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.2.5.3. Market Revenue and Volume Forecast, by End Use (2021-2034)

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.2.6.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.2.6.3. Market Revenue and Volume Forecast, by End Use (2021-2034)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.2.7.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.2.7.3. Market Revenue and Volume Forecast, by End Use (2021-2034)

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.3.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.3.3. Market Revenue and Volume Forecast, by End Use (2021-2034)

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.3.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.3.4.3. Market Revenue and Volume Forecast, by End Use (2021-2034)

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.3.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.3.5.3. Market Revenue and Volume Forecast, by End Use (2021-2034)

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.3.6.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.3.6.3. Market Revenue and Volume Forecast, by End Use (2021-2034)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.3.7.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.3.7.3. Market Revenue and Volume Forecast, by End Use (2021-2034)

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.4.3. Market Revenue and Volume Forecast, by End Use (2021-2034)

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.4.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.4.4.3. Market Revenue and Volume Forecast, by End Use (2021-2034)

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.4.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.4.5.3. Market Revenue and Volume Forecast, by End Use (2021-2034)

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.4.6.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.4.6.3. Market Revenue and Volume Forecast, by End Use (2021-2034)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.4.7.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.4.7.3. Market Revenue and Volume Forecast, by End Use (2021-2034)

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.5.3. Market Revenue and Volume Forecast, by End Use (2021-2034)

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.5.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.5.4.3. Market Revenue and Volume Forecast, by End Use (2021-2034)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.5.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.5.5.3. Market Revenue and Volume Forecast, by End Use (2021-2034)

Chapter 12. Company Profiles

12.1. Medtronic

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Stryker

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Terumo Corporation

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Integer Holdings Corporation

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Penumbra, Inc.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Johnson & Johnson Services, Inc.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Integra LifeSciences Corporation

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Acandis GmbH

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Spiegelberg GmbH & Co. KG

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client